These tools will no longer be maintained as of December 31, 2024. Archived website can be found here. PubMed4Hh GitHub repository can be found here. Contact NLM Customer Service if you have questions.


BIOMARKERS

Molecular Biopsy of Human Tumors

- a resource for Precision Medicine *

250 related articles for article (PubMed ID: 10698414)

  • 1. Anterior choroidal artery infarction presenting as a progressive cognitive deficit.
    Sarangi S; San Pedro EC; Mountz JM
    Clin Nucl Med; 2000 Mar; 25(3):187-90. PubMed ID: 10698414
    [TBL] [Abstract][Full Text] [Related]  

  • 2. [Molecular neuroimaging in the study of cognitive impairment: contribution of the cerebral blood flow SPECT with 99mTc-HMPAO and 18F-FDG PET/CT scan].
    Banzo I; Quirce R; Martínez-Rodríguez I; Jiménez-Bonilla J; Portilla-Quattrociocchi H; Medina-Quiroz P; Ortega F; Rodríguez E; Mateo I; Vázquez-Higuera JL; de Arcocha M; Carril JM
    Rev Esp Med Nucl; 2011; 30(5):301-6. PubMed ID: 21640440
    [TBL] [Abstract][Full Text] [Related]  

  • 3. Accurate prediction of histologically confirmed Alzheimer's disease and the differential diagnosis of dementia: the use of NINCDS-ADRDA and DSM-III-R criteria, SPECT, X-ray CT, and APO E4 medial temporal lobe dementias. The Oxford Project to Investigate Memory and Aging.
    Jobst KA; Barnetson LP; Shepstone BJ
    Int Psychogeriatr; 1997; 9 Suppl 1():191-222; discussion 247-52. PubMed ID: 9447442
    [TBL] [Abstract][Full Text] [Related]  

  • 4. Concordance between (99m)Tc-ECD SPECT and 18F-FDG PET interpretations in patients with cognitive disorders diagnosed according to NIA-AA criteria.
    Ito K; Shimano Y; Imabayashi E; Nakata Y; Omachi Y; Sato N; Arima K; Matsuda H
    Int J Geriatr Psychiatry; 2014 Oct; 29(10):1079-86. PubMed ID: 24687634
    [TBL] [Abstract][Full Text] [Related]  

  • 5. Combined magnetic resonance imaging and single-photon emission tomography scanning in the discrimination of Alzheimer's disease from age-matched controls.
    O'Brien JT; Ames D; Desmond P; Lichtenstein M; Binns D; Schweitzer I; Davis S; Tress B
    Int Psychogeriatr; 2001 Jun; 13(2):149-61. PubMed ID: 11495391
    [TBL] [Abstract][Full Text] [Related]  

  • 6. Brain perfusion follow-up in Alzheimer's patients during treatment with acetylcholinesterase inhibitors.
    Nobili F; Koulibaly M; Vitali P; Migneco O; Mariani G; Ebmeier K; Pupi A; Robert PH; Rodriguez G; Darcourt J
    J Nucl Med; 2002 Aug; 43(8):983-90. PubMed ID: 12163621
    [TBL] [Abstract][Full Text] [Related]  

  • 7. Regional cerebral blood flow differences in patients with mild cognitive impairment between those who did and did not develop Alzheimer's disease.
    Park KW; Yoon HJ; Kang DY; Kim BC; Kim S; Kim JW
    Psychiatry Res; 2012; 203(2-3):201-6. PubMed ID: 22980226
    [TBL] [Abstract][Full Text] [Related]  

  • 8. Hypofixation and hyperfixation of 99mTc-hexamethyl propyleneamine oxime in subacute cerebral infarction.
    Ogasawara K; Ogawa A; Koshu K; Konno H; Suzuki M; Yoshimoto T
    J Nucl Med; 2000 May; 41(5):795-9. PubMed ID: 10809194
    [TBL] [Abstract][Full Text] [Related]  

  • 9. Pattern of cerebral hypoperfusion in Alzheimer disease and mild cognitive impairment measured with arterial spin-labeling MR imaging: initial experience.
    Johnson NA; Jahng GH; Weiner MW; Miller BL; Chui HC; Jagust WJ; Gorno-Tempini ML; Schuff N
    Radiology; 2005 Mar; 234(3):851-9. PubMed ID: 15734937
    [TBL] [Abstract][Full Text] [Related]  

  • 10. Correlation of neuropsychological, morphological and functional (regional cerebral blood flow and glucose utilization) findings in cerebral microangiopathy.
    Sabri O; Hellwig D; Schreckenberger M; Cremerius U; Schneider R; Kaiser HJ; Doherty C; Mull M; Ringelstein EB; Buell U
    J Nucl Med; 1998 Jan; 39(1):147-54. PubMed ID: 9443754
    [TBL] [Abstract][Full Text] [Related]  

  • 11. The diagnostic value of magnetic resonance imaging and technetium 99m-HMPAO single-photon-emission computed tomography for the diagnosis of Alzheimer disease in a community-dwelling elderly population.
    Scheltens P; Launer LJ; Barkhof F; Weinstein HC; Jonker C
    Alzheimer Dis Assoc Disord; 1997 Jun; 11(2):63-70. PubMed ID: 9194952
    [TBL] [Abstract][Full Text] [Related]  

  • 12. Longitudinal changes in cognitive function and regional cerebral function in Alzheimer's disease: a SPECT blood flow study.
    Brown DR; Hunter R; Wyper DJ; Patterson J; Kelly RC; Montaldi D; McCullouch J
    J Psychiatr Res; 1996; 30(2):109-26. PubMed ID: 8816305
    [TBL] [Abstract][Full Text] [Related]  

  • 13. Effect of linearization correction on statistical parametric mapping (SPM): a 99mTc-HMPAO brain perfusion SPECT study in mild Alzheimer's disease.
    Ansar MA; Osaki Y; Kazui H; Oku N; Takasawa M; Kimura Y; Begum NN; Ikejiri Y; Takeda M; Hatazawa J
    Ann Nucl Med; 2006 Oct; 20(8):511-7. PubMed ID: 17134017
    [TBL] [Abstract][Full Text] [Related]  

  • 14. Single photon emission computed tomography imaging of cerebral blood flow, blood-brain barrier disruption, and apoptosis time course after focal cerebral ischemia in rats.
    Garrigue P; Giacomino L; Bucci C; Muzio V; Filannino MA; Sabatier F; Dignat-George F; Pisano P; Guillet B
    Int J Stroke; 2016 Jan; 11(1):117-26. PubMed ID: 26763027
    [TBL] [Abstract][Full Text] [Related]  

  • 15. Embolic distribution through patent foramen ovale demonstrated by (99m)Tc-MAA brain SPECT after Valsalva radionuclide venography.
    Hayashida K; Fukuchi K; Inubushi M; Fukushima K; Imakita S; Kimura K
    J Nucl Med; 2001 Jun; 42(6):859-63. PubMed ID: 11390548
    [TBL] [Abstract][Full Text] [Related]  

  • 16. Technetium HMPAO SPECT study in dementia with Lewy bodies, Alzheimer's disease and idiopathic Parkinson's disease.
    Defebvre LJ; Leduc V; Duhamel A; Lecouffe P; Pasquier F; Lamy-Lhullier C; Steinling M; Destée A
    J Nucl Med; 1999 Jun; 40(6):956-62. PubMed ID: 10452310
    [TBL] [Abstract][Full Text] [Related]  

  • 17. Accurate prediction of histologically confirmed Alzheimer's disease and the differential diagnosis of dementia: the use of NINCDS-ADRDA and DSM-III-R criteria, SPECT, X-ray CT, and Apo E4 in medial temporal lobe dementias. Oxford Project to Investigate Memory and Aging.
    Jobst KA; Barnetson LP; Shepstone BJ
    Int Psychogeriatr; 1998 Sep; 10(3):271-302. PubMed ID: 9785148
    [TBL] [Abstract][Full Text] [Related]  

  • 18. Pediatric cerebrovascular disease. Alterations of regional cerebral blood flow detected by TC 99m-HMPAO SPECT.
    Shahar E; Gilday DL; Hwang PA; Cohen EK; Lambert R
    Arch Neurol; 1990 May; 47(5):578-84. PubMed ID: 2334307
    [TBL] [Abstract][Full Text] [Related]  

  • 19. HMPAO SPET and FDG PET in Alzheimer's disease and vascular dementia: comparison of perfusion and metabolic pattern.
    Mielke R; Pietrzyk U; Jacobs A; Fink GR; Ichimiya A; Kessler J; Herholz K; Heiss WD
    Eur J Nucl Med; 1994 Oct; 21(10):1052-60. PubMed ID: 7828614
    [TBL] [Abstract][Full Text] [Related]  

  • 20. Brain energy metabolism in Alzheimer's disease: 99mTc-HMPAO SPECT imaging during verbal fluency and role of astrocytes in the cellular mechanism of 99mTc-HMPAO retention.
    Slosman DO; Ludwig C; Zerarka S; Pellerin L; Chicherio C; de Ribaupierre A; Annoni JM; Bouras C; Herrmann F; Michel JP; Giacobini E; Magistretti PJ
    Brain Res Brain Res Rev; 2001 Oct; 36(2-3):230-40. PubMed ID: 11690620
    [TBL] [Abstract][Full Text] [Related]  

    [Next]    [New Search]
    of 13.